Market closedNon-fractional
Milestone Pharmaceuticals/MIST
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Milestone Pharmaceuticals
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia (PSVT) with a subsequent indication to treat atrial fibrillation with rapid ventricular rate (AFib-RVR) and other cardiovascular indications.
Ticker
MIST
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology & Drugs
Headquarters
Montreal, Canada
Employees
47
Website
www.milestonepharma.com
MIST Metrics
BasicAdvanced
$80M
Market cap
-
P/E ratio
-$1.25
EPS
1.73
Beta
-
Dividend rate
Price and volume
Market cap
$80M
Beta
1.73
52-week high
$4.10
52-week low
$1.33
Average daily volume
4.9
Financial strength
Current ratio
22.752
Long term debt to equity
126.861
Total debt to equity
126.861
Management effectiveness
Return on assets (TTM)
-53.21%
Return on equity (TTM)
-117.39%
Return on investment (TTM)
-56.51%
Valuation
Price to book
2.001
Price to tangible book (TTM)
2.001
Growth
Revenue change (TTM)
-100.00%
Earnings per share change (TTM)
10.49%
What the Analysts think about MIST
Analyst Ratings
Majority rating from 4 analysts.
MIST Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$10M
-24.26%
Profit margin
0.00%
NaN%
MIST Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.37
-$0.35
-$0.32
-$0.21
-
Expected
-$0.39
-$0.38
-$0.31
-$0.26
-$0.19
Surprise
-4.15%
-8.38%
2.40%
-19.23%
-
MIST News
AllArticlesVideos
Milestone Pharmaceuticals to Host KOL Event for Investors “Learnings from the Field: Expert Perspectives on PSVT in the Community Setting” on June 20, 2024
GlobeNewsWire·1 month ago
Milestone® Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare Conference
GlobeNewsWire·2 months ago
Milestone Pharmaceuticals Announces FDA Acceptance of New Drug Application for CARDAMYST™
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Milestone Pharmaceuticals stock?
Milestone Pharmaceuticals (MIST) has a market cap of $80M as of July 26, 2024.
What is the P/E ratio for Milestone Pharmaceuticals stock?
The price to earnings (P/E) ratio for Milestone Pharmaceuticals (MIST) stock is 0 as of July 26, 2024.
Does Milestone Pharmaceuticals stock pay dividends?
No, Milestone Pharmaceuticals (MIST) stock does not pay dividends to its shareholders as of July 26, 2024.
When is the next Milestone Pharmaceuticals dividend payment date?
Milestone Pharmaceuticals (MIST) stock does not pay dividends to its shareholders.
What is the beta indicator for Milestone Pharmaceuticals?
Milestone Pharmaceuticals (MIST) has a beta rating of 1.73. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Milestone Pharmaceuticals stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.